Corporate News | 08/10/2023

RHÖN-KLINIKUM Aktiengesellschaft: RHÖN-KLINIKUM AG publishes result for first half of 2023 – outlook confirmed

EQS-News: RHÖN-KLINIKUM Aktiengesellschaft / Key word(s): Half Year Results/MiscellaneousRHÖN-KLINIKUM Aktiengesellschaft: RHÖN-KLINIKUM AG publishes result for first half of 2023 – outlook confirmed 10.08.2023 / 09:03 CET/CESTThe issuer is solely responsible for the content of this announcement.

Corporate News

Bad Neustadt a. d. Saale | 10 August 2023


RHÖN-KLINIKUM AG publishes result for first half of 2023 – outlook confirmed

RHÖN-KLINIKUM AG closed the first half of 2023 with a 2.4 per cent increase in revenues to 728.2 million euros (2022: 711.2 million euros). From January to June 2023 a total of 446,022 patients were treated on an inpatient and outpatient basis in the hospitals and medical care centres of RHÖN-KLINIKUM AG,4.4% more compared with the same period of the previous year (2022: 427,344).

At 45.2 million euros, EBITDA fell short of the previous year’s level (2022: 52.8 million euros). Materialsand consumables used increased as a result of higher purchasing prices to 237.0 million euros(2022: 214.0 million euros). Taking account of depreciation/amortisation, financing costs and taxes,EBITDA results in a consolidated profit of 12.2 million euros (2022: 12.8 million euros).

The key figures of the first six months are influenced by two main developments: on the one hand,by the still persisting inflation, coping with the impacts of higher energy and commodity prices, as wellas the geopolitical risks brought about by the war in Ukraine. On the other hand, by a weekslong strikeat Universitätsklinikum Gießen und Marburg (UKGM) early this year, which resulted in massive cuts in outpatient and inpatient care.

Now that UKGM and the trade union ver.di on 14 April 2023 reached agreement on a key issues paper for the conclusion of a “job protection and relief collective agreement for UKGM and UKGM Service GmbH”, efforts are now successfully being turned towards overcoming the economic consequences of the strike.

This will enable us to seize the opportunities arising from an agreement signed at the end of February 2023 between the Federal State of Hesse, the Universities of Giessen and Marburg, Universitätsklinikum Gießen und Marburg (UKGM) and RHÖN-KLINIKUM AG on UKGM’s entitlement to investment funding. After RHÖN-KLINIKUM AG already in the past had invested over 750 million euros at UKGM from own funds, the next ten years will now see further amounts totalling nearly 850 million euros being invested in healthcare delivery, research and teaching. At the same time, federal state funding totalling roughly 529 million euros coupled with investments of roughly 319 million euros from own funds will enable the two hospitals to keep pace with medical, technical and structural developments in order to continue providing cutting-edge university medical care also in future.


For the current financial year 2023 we continue to expect revenues of 1.5 billion euros within a range of+/- 5 per cent. For earnings before interest, tax and depreciation/amortisation (EBITDA), we expect a level of between 103 million euros and 109 million euros.

The outlook is further subject to considerable uncertainties in connection with the geopolitical risks brought about by the war in Ukraine and any regulatory measures impacting our remuneration structure in 2023.

Full results are published in the Half-Year Report at:


RHÖN-KLINIKUM AG is one of the largest healthcare providers in Germany. The hospitals offer excellent medical care with a direct tie-in to universities and research facilities. Each year some 855,000 patients are treated at our five sites of Campus Bad Neustadt, Klinikum Frankfurt (Oder), Universitätsklinikum Gießen and Universitätsklinikum Marburg (UKGM) as well as Zentralklinik Bad Berka. The Company employs over 18,100 persons. The innovative RHÖN Campus approach for cross-sector and future-oriented healthcare delivery in rural areas, the steadfast continuation of the gradual digital transformation within the Company as well as the strategic partnership with Asklepios are important elements of our corporate strategy. RHÖN-KLINIKUM AG is an independent Company operating under the umbrella of Asklepios Kliniken GmbH & Co. KGaA.


RHÖN-KLINIKUM AG | Head of Corporate Finance, Treasury, Investor Relations and SustainabilityJulian Schmitt | T. +49 9771 65-12250 | julian.schmitt(at)rhoen-klinikum-ag.comRHÖN-KLINIKUM AG | Schlossplatz 1 | D-97616 Bad Neustadt a. d. Saale

10.08.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.Archive at

Language: English
Company: RHÖN-KLINIKUM Aktiengesellschaft
Salzburger Leite 1
97616 Bad Neustadt a.d.Saale
Phone: +49 (0)9771 - 65-0
Fax: +49 (0)9771 - 97 467
ISIN: DE0007042301
WKN: 704230
Listed: Regulated Market in Frankfurt (Prime Standard), Munich; Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Stuttgart, Tradegate Exchange
EQS News ID: 1700339
End of News EQS News Service

show this